Multidimensional Evaluation of Awareness in Prader-Willi Syndrome.

BMI Prader-Willi Syndrome awareness functionality insight obesity

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
07 May 2021
Historique:
received: 05 04 2021
revised: 30 04 2021
accepted: 06 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

There are no studies about insight or awareness of illness in patients with Prader-Willi Syndrome (PWS). The objective of this study was to explore the level of awareness of the disorder, of the need for medication, and of the social consequences of the disease, as well as of its main symptoms in PWS. We also aimed to explore relationships between awareness and sociodemographic and clinical characteristics, and to compare all data with a matched sample of patients with psychosis. Insight was assessed by an Adapted version of the Scale of Unawareness of Mental Disorder in a cross-sectional pilot study at a University Hospital. Thirty-six individuals with PWS (58.3% women) were included. Results showed that PWS patients had a good awareness of the illness and of the effects of medication, in contrast to a lack of awareness of illness' social consequences. Awareness of obesity/overweight was excellent, as was the awareness of excessive appetite. Awareness of excessive food intake was only mild. Insight correlated with age and functionality, but not with BMI. PWS patients showed a better insight into the illness but a similar awareness of the effects of the medication and of the social consequences of the disease as compared to schizophrenia-spectrum patients. This profile of insight may have relevant clinical implications.

Identifiants

pubmed: 34067179
pii: jcm10092007
doi: 10.3390/jcm10092007
pmc: PMC8125854
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fondo de Investigación Sanitaria del Instituto Carlos III and Fondo Europeo de Desarrollo Regional
ID : PI-18/0734

Références

Front Pediatr. 2018 May 03;6:102
pubmed: 29774207
Br J Psychiatry. 1995 Nov;167(5):621-8
pubmed: 8564318
Expert Rev Mol Med. 2005 Jul 25;7(14):1-20
pubmed: 16038620
Ann Gen Psychiatry. 2009 Aug 26;8:20
pubmed: 19709422
Res Dev Disabil. 2013 Oct;34(10):3343-51
pubmed: 23911544
J Endocrinol Invest. 2015 Dec;38(12):1249-63
pubmed: 26062517
Psychiatry Res. 2008 Feb 28;158(1):1-10
pubmed: 18166230
Psychopathology. 2012;45(2):109-16
pubmed: 22310493
Psychiatry Res. 2017 Jun;252:147-153
pubmed: 28273629
Philos Trans R Soc Lond B Biol Sci. 2012 May 19;367(1594):1379-90
pubmed: 22492754
Med Clin (Barc). 2022 Aug 12;159(3):130-133
pubmed: 34696903
Acta Psychiatr Scand. 1988 Jan;77(1):74-6
pubmed: 2894746
Curr Pediatr Rev. 2019;15(4):207-244
pubmed: 31333129
PLoS One. 2018 Mar 26;13(3):e0194655
pubmed: 29579119
Psychol Med. 1998 Mar;28(2):437-46
pubmed: 9572100
Actas Esp Psiquiatr. 2008 Mar-Apr;36(2):111-1198
pubmed: 18365791
Psychiatry Res. 2016 Sep 30;243:268-77
pubmed: 27423634
Curr Pediatr Rev. 2016;12(2):136-66
pubmed: 26592417
Curr Opin Psychiatry. 2006 Jul;19(4):367-72
pubmed: 16721165
J Med Genet. 2001 Nov;38(11):792-8
pubmed: 11732491
Neurosci Biobehav Rev. 2017 Jan;72:153-167
pubmed: 27836461
Br J Psychiatry. 1990 Jun;156:798-808
pubmed: 2207510
J Autism Dev Disord. 2020 Mar;50(3):893-903
pubmed: 31802317
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994 Jul-Aug;22(4):171-7
pubmed: 7810373
J Child Psychol Psychiatry. 2008 Sep;49(9):1001-8
pubmed: 18665884
Arch Womens Ment Health. 2020 Oct;23(5):643-655
pubmed: 32385644
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Neurologia. 2010 Sep;25(7):422-9
pubmed: 20964988
Psychiatr Q. 1993 Winter;64(4):305-18
pubmed: 8234544
Int J Soc Psychiatry. 2015 Jun;61(4):379-85
pubmed: 25182810
Actas Esp Psiquiatr. 2019 May;47(3):79-87
pubmed: 31233206
Arch Gen Psychiatry. 1976 Jun;33(6):766-71
pubmed: 938196
Rev Neurol. 2003 Feb;36 Suppl 1:S153-7
pubmed: 12599118
Compr Psychiatry. 1995 Sep-Oct;36(5):367-76
pubmed: 7497711
Br J Psychiatry. 2006 Sep;189:204-12
pubmed: 16946354
Psychiatry Res. 2011 Sep 30;189(2):161-5
pubmed: 21813183
Schizophr Bull. 2007 Nov;33(6):1324-42
pubmed: 17289653
Compr Psychiatry. 2012 Jul;53(5):502-8
pubmed: 22036010
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
Br J Psychiatry. 1996 Oct;169(4):444-50
pubmed: 8894195
Tijdschr Psychiatr. 2016;58(6):455-62
pubmed: 27320509
Endocrinol Diabetes Nutr (Engl Ed). 2019 Nov;66(9):579-587
pubmed: 31006652
J Intellect Disabil Res. 2020 Feb;64(2):158-169
pubmed: 31849130
Rev Esp Salud Publica. 2012 Jul-Aug;86(4):445-51
pubmed: 23076089
Genes (Basel). 2019 Dec 09;10(12):
pubmed: 31835392
Arch Gen Psychiatry. 1994 Oct;51(10):826-36
pubmed: 7944872
Cogn Neuropsychiatry. 2008 May;13(3):210-32
pubmed: 18484288
PLoS One. 2013 Aug 14;8(8):e72640
pubmed: 23967326
Clin Genet. 2018 Mar;93(3):622-631
pubmed: 28984907
Psychiatry Res. 2018 Jun;264:340-345
pubmed: 29674224
Schizophr Res. 2017 Nov;189:61-68
pubmed: 28237605
Endocrinol Diabetes Nutr (Engl Ed). 2018 Apr;65(4):229-236
pubmed: 29510967

Auteurs

Jesús Cobo (J)

Mental Health Department, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona-CIBERSAM, 08208 Sabadell, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Insight Barcelona Research Group, Societat Catalana de Psiquiatria i Salut Mental, 08017 Barcelona, Spain.

Ramón Coronas (R)

Mental Health Department, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona-CIBERSAM, 08208 Sabadell, Spain.
Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.

Esther Pousa (E)

Insight Barcelona Research Group, Societat Catalana de Psiquiatria i Salut Mental, 08017 Barcelona, Spain.
Psychiatry Department, Hospital Universitari St. Pau, 08041 Barcelona, Spain.

Joan-Carles Oliva (JC)

Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Statistic Unit, Fundació Parc Taulí I3PT, 08208 Sabadell, Spain.

Olga Giménez-Palop (O)

Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Endocrinology and Nutrition Department, Hospital Universitari Parc Taulí, Corporació Sanitària ParcTaulí-Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
Medicine Department, Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.

Susanna Esteba-Castillo (S)

Specialized Service in Mental Health and Intellectual Disability, Institut Assistència Sanitària (IAS), Parc Hospitalari Martí i Julià, Salt, 17190 Girona, Spain.
Neurodevelopment Group, Girona Biomedical Research Institute-IDIBGI, Institut Assistència Sanitària (IAS), Parc Hospitalari Martí i Julià, Salt, 17190 Girona, Spain.

Ramon Novell (R)

Specialized Service in Mental Health and Intellectual Disability, Institut Assistència Sanitària (IAS), Parc Hospitalari Martí i Julià, Salt, 17190 Girona, Spain.
Neurodevelopment Group, Girona Biomedical Research Institute-IDIBGI, Institut Assistència Sanitària (IAS), Parc Hospitalari Martí i Julià, Salt, 17190 Girona, Spain.

Diego J Palao (DJ)

Mental Health Department, Corporació Sanitària Parc Taulí, Universitat Autònoma de Barcelona-CIBERSAM, 08208 Sabadell, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.

Assumpta Caixàs (A)

Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.
Endocrinology and Nutrition Department, Hospital Universitari Parc Taulí, Corporació Sanitària ParcTaulí-Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
Medicine Department, Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.

Classifications MeSH